The Patent Finder
OT

Orpro Therapeutics, Inc.

First filing 2014
OverviewNotableFeesChangesFamiliesPatent listSources & methods

Two patents currently held, every record listed here

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next US patent term in the Orpro Therapeutics, Inc. portfolio ends in Mar 2034. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Mar 2034
Next term end
1
Patent families

When these terms end

Each bar runs from grant to computed term end. 2015 to 2034.
US 9,168,290 Product and Process for Mucus Viscosity Normalization Mar 19, 2034
US 12,390,511 Product and Process for Mucus Viscosity Normalization Mar 19, 2034
20192023202720312034
3 pending applications: term is not computable until grant.Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 1 of the currently held patents qualifies as notable.

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Apr 27, 2027
    The maintenance fee for Product and Process for Mucus Viscosity Normalization (US 9,168,290) comes due Apr 27, 2027. Unpaid by Oct 27, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 2 of 2

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 9,168,290Product and Process for Mucus Viscosity Normalization
In force
 · High confidence
In forceHigh confidence
US 12,390,511Product and Process for Mucus Viscosity Normalization
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 2: 3 applications pending · 2 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited